NR6A1 and lung adenocarcinoma: Analysis of CPTAC data revealed significantly increased protein expression of p-mTOR (Ser2448) in stage III lung adenocarcinoma patients(Fig. 3I).In addition, Pearson correlation analysis of data from the TCGA database revealed that the levels of the mTOR and NR6A1 mRNAs were positively correlated in patients with lung adenocarcinoma (R = 0.27, P = 2.2e-15) (Fig. 3J).